Literature DB >> 21097500

SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes.

Samyuktha Muralidharan Pillai1, David Meredith.   

Abstract

The SLC36 family of transporters consists of four genes, two of which, SLC36A1 and SLC36A2, have been demonstrated to code for human proton-coupled amino acid transporters or hPATs. Here we report the characterization of the fourth member of the family, SLC36A4 or hPAT4, which when expressed in Xenopus laevis oocytes also encodes a plasma membrane amino acid transporter, but one that is not proton-coupled and has a very high substrate affinity for the amino acids proline and tryptophan. hPAT4 in Xenopus oocytes mediated sodium-independent, electroneutral uptake of [(3)H]proline, with the highest rate of uptake when the uptake medium pH was 7.4 and an affinity of 3.13 μM. Tryptophan was also an excellently transported substrate with a similarly high affinity (1.72 μM). Other amino acids that inhibited [(3)H]proline were isoleucine (K(i) 0.23 mM), glutamine (0.43 mM), methionine (0.44 mM), and alanine (1.48 mM), and with lower affinity, glycine, threonine, and cysteine (K(i) >5 mM for all). Of the amino acids directly tested for transport, only proline, tryptophan, and alanine showed significant uptake, whereas glycine and cysteine did not. Of the non-proteogenic amino acids and drugs tested, only sarcosine produced inhibition (K(i) 1.09 mM), whereas γ-aminobutyric acid (GABA), β-alanine, L-Dopa, D-serine, and δ-aminolevulinic acid were without effect on [(3)H]proline uptake. This characterization of hPAT4 as a very high affinity/low capacity non-proton-coupled amino acid transporter raises questions about its physiological role, especially as the transport characteristics of hPAT4 are very similar to the Drosophila orthologue PATH, an amino acid "transceptor" that plays a role in nutrient sensing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097500      PMCID: PMC3024739          DOI: 10.1074/jbc.M110.172403

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  THE TRANSFER SYSTEM FOR NEUTRAL AMINO ACIDS IN THE RAT SMALL INTESTINE.

Authors:  H NEWEY; D H SMYTH
Journal:  J Physiol       Date:  1964-03       Impact factor: 5.182

2.  PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids.

Authors:  Deborah C I Goberdhan; David Meredith; C A Richard Boyd; Clive Wilson
Journal:  Development       Date:  2005-04-20       Impact factor: 6.868

Review 3.  The molecular basis of neutral aminoacidurias.

Authors:  Angelika Bröer; Juleen A Cavanaugh; John E J Rasko; Stefan Bröer
Journal:  Pflugers Arch       Date:  2005-07-29       Impact factor: 3.657

4.  H+/amino acid transporter 1 (PAT1) is the imino acid carrier: An intestinal nutrient/drug transporter in human and rat.

Authors:  Catriona M H Anderson; Danielle S Grenade; Michael Boll; Martin Foltz; Katherine A Wake; David J Kennedy; Lars K Munck; Seiji Miyauchi; Peter M Taylor; Frederick Charles Campbell; Bjarne G Munck; Hannelore Daniel; Vadivel Ganapathy; David T Thwaites
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Serotonin, L-tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1.

Authors:  Linda Metzner; Gabor Kottra; Klaus Neubert; Hannelore Daniel; Matthias Brandsch
Journal:  FASEB J       Date:  2005-09       Impact factor: 5.191

6.  Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation.

Authors:  S Heublein; S Kazi; M H Ogmundsdóttir; E V Attwood; S Kala; C A R Boyd; C Wilson; D C I Goberdhan
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

7.  The determination of kinetic parameters for carrier-mediated transport of non-labelled substrate analogues: a general method applied to the study of divalent anion transport in placental membrane vesicles.

Authors:  R Deves; C A Boyd
Journal:  Proc R Soc Lond B Biol Sci       Date:  1989-06-22

8.  Substrate specificity and functional characterisation of the H+/amino acid transporter rat PAT2 (Slc36a2).

Authors:  David J Kennedy; Kelly M Gatfield; John P Winpenny; Vadivel Ganapathy; David T Thwaites
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

9.  Site-directed mutation of arginine 282 to glutamate uncouples the movement of peptides and protons by the rabbit proton-peptide cotransporter PepT1.

Authors:  David Meredith
Journal:  J Biol Chem       Date:  2004-01-10       Impact factor: 5.157

10.  Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos.

Authors:  I Dominguez; K Itoh; S Y Sokol
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more
  17 in total

Review 1.  The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport.

Authors:  David T Thwaites; Catriona M H Anderson
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

2.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Dennd3 functions as a guanine nucleotide exchange factor for small GTPase Rab12 in mouse embryonic fibroblasts.

Authors:  Takahide Matsui; Kenta Noguchi; Mitsunori Fukuda
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

4.  Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.

Authors:  Shotaro Sasaki; Yuya Futagi; Masaki Kobayashi; Jiro Ogura; Ken Iseki
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

Review 5.  Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.

Authors:  Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

6.  Rab12 regulates mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4.

Authors:  Takahide Matsui; Mitsunori Fukuda
Journal:  EMBO Rep       Date:  2013-03-12       Impact factor: 8.807

7.  Functions of the SLC36 transporter Pathetic in growth control.

Authors:  Wen-Yang Lin; Claire R Williams; Connie Yan; Jay Z Parrish
Journal:  Fly (Austin)       Date:  2015       Impact factor: 2.160

8.  The current progress and future prospects of personalized radiogenomic cancer study.

Authors:  Juhn-Cherng Liu; Wu-Chung Shen; Tzu-Ching Shih; Chia-Wen Tsai; Wen-Shin Chang; Der-Yang Cho; Chang-Hai Tsai; Da-Tian Bau
Journal:  Biomedicine (Taipei)       Date:  2015-02-02

9.  PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.

Authors:  S-J Fan; C Snell; H Turley; J-L Li; R McCormick; S M W Perera; S Heublein; S Kazi; A Azad; C Wilson; A L Harris; D C I Goberdhan
Journal:  Oncogene       Date:  2015-10-05       Impact factor: 9.867

10.  Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes.

Authors:  Margrét H Ögmundsdóttir; Sabine Heublein; Shubana Kazi; Bruno Reynolds; Shivanthy M Visvalingam; Michael K Shaw; Deborah C I Goberdhan
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.